ID

14786

Beschreibung

A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Patients With Early Stage Triple Negative Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02301988

Link

https://clinicaltrials.gov/show/NCT02301988

Stichworte

Versionen (1)
  1. 28.04.16 28.04.16 -
Hochgeladen am

28. April 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT02301988

Englisch

Eligibility Breast Cancer NCT02301988

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
premenopausal or postmenopausal women, age >/=18 years
Beschreibung

Gender | Premenopausal state | Postmenopausal state | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0232969
UMLS CUI [3]
C0232970
UMLS CUI [4]
C0001779
eastern cooperative oncology group (ecog) performance status of 0 or 1
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
histologically documented, stage ia to operable stage iiia, triple-negative carcinoma of the breast with primary tumor >/=1.5 cm in largest diameter (ct1-3) by magnetic resonance imaging (mri)
Beschreibung

malignant neoplasm of breast staging | Triple-Negative Breast Cancer Finding | primary tumor | Magnetic Resonance Imaging

Datentyp

boolean

Alias
UMLS CUI [1]
C2216702
UMLS CUI [2]
C2348819
UMLS CUI [3]
C0677930
UMLS CUI [4]
C0024485
adequate hematologic and organ function within 14 days before the first study treatment
Beschreibung

Hematologic function | body system or organ function | Therapies, Investigational

Datentyp

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0678852
UMLS CUI [3]
C0949266
availability of tumor tissue from formalin-fixed, paraffin-embedded (ffpe) core biopsy of breast primary tumor
Beschreibung

Tumor tissue sample Formalin-fixed paraffin-embedded tissue specimen Core biopsy of breast primary tumor

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0475358
UMLS CUI [1,2]
C2711483
UMLS CUI [1,3]
C0842740
UMLS CUI [1,4]
C0677930
for female patients of childbearing potential, agreement to use highly effective form(s) of contraception for the duration of the study and for at least 6 months after last dose of study treatment
Beschreibung

Gender | Childbearing Potential Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
known her2-positive, er-positive, or pgr-positive breast cancer
Beschreibung

HER2-positive carcinoma of breast | ESTROGEN RECEPTOR (ER) OR PROGESTERONE RECEPTOR (PR) POSITIVE BREAST CANCER

Datentyp

boolean

Alias
UMLS CUI [1]
C1960398
UMLS CUI [2]
C1971473
any prior treatment for the current primary invasive breast cancer
Beschreibung

Prior Therapy Invasive breast carcinoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0853879
patients with ct4 or cn3 stage breast tumors
Beschreibung

malignant neoplasm of breast staging

Datentyp

boolean

Alias
UMLS CUI [1]
C2216702
metastatic (stage iv) breast cancer
Beschreibung

Carcinoma breast stage IV

Datentyp

boolean

Alias
UMLS CUI [1]
C0278488
bilateral invasive breast cancer
Beschreibung

Invasive breast carcinoma Bilateral

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0238767
multicentric breast cancer
Beschreibung

Multicentric Breast Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C2986664
any disease, metabolic dysfunction, physical examination finding, or clinical laboratory finding that contraindicates the use of an investigational drug or that may affect the interpretation of the results or render the patient at high risk from treatment complications
Beschreibung

Disease | Metabolic Dysfunction | Physical Examination | Laboratory test finding | Contraindication Investigational New Drugs | Affecting research results | Complications of treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C0012634
UMLS CUI [2,1]
C0311400
UMLS CUI [2,2]
C3887504
UMLS CUI [3]
C0031809
UMLS CUI [4]
C0587081
UMLS CUI [5,1]
C0522473
UMLS CUI [5,2]
C0013230
UMLS CUI [6,1]
C0392760
UMLS CUI [6,2]
C0683954
UMLS CUI [7]
C0679861
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT02301988

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Premenopausal state | Postmenopausal state | Age
Item
premenopausal or postmenopausal women, age >/=18 years
boolean
C0079399 (UMLS CUI [1])
C0232969 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
C0001779 (UMLS CUI [4])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
malignant neoplasm of breast staging | Triple-Negative Breast Cancer Finding | primary tumor | Magnetic Resonance Imaging
Item
histologically documented, stage ia to operable stage iiia, triple-negative carcinoma of the breast with primary tumor >/=1.5 cm in largest diameter (ct1-3) by magnetic resonance imaging (mri)
boolean
C2216702 (UMLS CUI [1])
C2348819 (UMLS CUI [2])
C0677930 (UMLS CUI [3])
C0024485 (UMLS CUI [4])
Hematologic function | body system or organ function | Therapies, Investigational
Item
adequate hematologic and organ function within 14 days before the first study treatment
boolean
C0221130 (UMLS CUI [1])
C0678852 (UMLS CUI [2])
C0949266 (UMLS CUI [3])
Tumor tissue sample Formalin-fixed paraffin-embedded tissue specimen Core biopsy of breast primary tumor
Item
availability of tumor tissue from formalin-fixed, paraffin-embedded (ffpe) core biopsy of breast primary tumor
boolean
C0475358 (UMLS CUI [1,1])
C2711483 (UMLS CUI [1,2])
C0842740 (UMLS CUI [1,3])
C0677930 (UMLS CUI [1,4])
Gender | Childbearing Potential Contraceptive methods
Item
for female patients of childbearing potential, agreement to use highly effective form(s) of contraception for the duration of the study and for at least 6 months after last dose of study treatment
boolean
C0079399 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
HER2-positive carcinoma of breast | ESTROGEN RECEPTOR (ER) OR PROGESTERONE RECEPTOR (PR) POSITIVE BREAST CANCER
Item
known her2-positive, er-positive, or pgr-positive breast cancer
boolean
C1960398 (UMLS CUI [1])
C1971473 (UMLS CUI [2])
Prior Therapy Invasive breast carcinoma
Item
any prior treatment for the current primary invasive breast cancer
boolean
C1514463 (UMLS CUI [1,1])
C0853879 (UMLS CUI [1,2])
malignant neoplasm of breast staging
Item
patients with ct4 or cn3 stage breast tumors
boolean
C2216702 (UMLS CUI [1])
Carcinoma breast stage IV
Item
metastatic (stage iv) breast cancer
boolean
C0278488 (UMLS CUI [1])
Invasive breast carcinoma Bilateral
Item
bilateral invasive breast cancer
boolean
C0853879 (UMLS CUI [1,1])
C0238767 (UMLS CUI [1,2])
Multicentric Breast Carcinoma
Item
multicentric breast cancer
boolean
C2986664 (UMLS CUI [1])
Disease | Metabolic Dysfunction | Physical Examination | Laboratory test finding | Contraindication Investigational New Drugs | Affecting research results | Complications of treatment
Item
any disease, metabolic dysfunction, physical examination finding, or clinical laboratory finding that contraindicates the use of an investigational drug or that may affect the interpretation of the results or render the patient at high risk from treatment complications
boolean
C0012634 (UMLS CUI [1])
C0311400 (UMLS CUI [2,1])
C3887504 (UMLS CUI [2,2])
C0031809 (UMLS CUI [3])
C0587081 (UMLS CUI [4])
C0522473 (UMLS CUI [5,1])
C0013230 (UMLS CUI [5,2])
C0392760 (UMLS CUI [6,1])
C0683954 (UMLS CUI [6,2])
C0679861 (UMLS CUI [7])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video